Form 4: Burdick Kenneth A sold LFST
Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 124,228 shares of LFST at an average $14.31, roughly $1,777,703, in a Form 4 filed 2026-11-18.
| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | 4 | 4 | 3 | 75% | -1.0% | -1.3% |
| 3d | 3 | 3 | 2 | 67% | -2.2% | -0.5% |
| 1w | 2 | 2 | 1 | 50% | -1.1% | -1.1% |
| 1m | 1 | 1 | 0 | 0% | +6.1% | +6.1% |
| 3m | 1 | 1 | 0 | 0% | +17.6% | +17.6% |
| 6m | 0 | 0 | 0 | — | — | — |
| 1y | 0 | 0 | 0 | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 124,228 shares of LFST at an average $14.31, roughly $1,777,703, in a Form 4 filed 2026-11-18.
Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 159,624 shares of LFST at an average $14.31, roughly $2,284,219, in a Form 4 filed 2026-11-16.
Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 141,589 shares of LFST at an average $14.51, roughly $2,054,547, in a Form 4 filed 2026-11-12.
Burdick Kenneth A (Director at LifeStance Health Group, Inc.) reported an open-market sale of 500,000 shares of LFST at an average $11.51, roughly $5,755,000, in a Form 4 filed 2026-08-13.
End of results.